Skip to main content

Table 2 Antiretroviral drugs included in SQV/r regimens.

From: The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naïve and pre-treated but protease inhibitor (PI)- naïve hiv-infected patients

   ART-naïve Pretreated but PI-naïve
   n % n %
2 NRTI   129   74   54   59.5  
  TDF/FTC   82   47   38   35
  AZT/3TC   29   17   4   4
  3TC/ABC   14   8   8   7
PI   19   11   30   27.5  
  LPV   19   11   20   18
  ATV   0     6   5.5
  FAP   0     4   4
PI + NRTI/NNRTI   5   3   8   7  
  LPV   2     5   4.5
  ATV   2     3   2.5
  FAP   1     0   2
Not specified   0   0   1   1  
Other   22   12   16   15  
  1. NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; TDF: tenofovir; FTC: emtricitabine; AZT: zidovudine; 3TC: lamivudine; ABC: abacavir; LPV: lopinavir; ATV: atazanavir; FAP: fosamprenavir